Planta Med 2019; 85(05): 394-405
DOI: 10.1055/a-0810-7738
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Inhibitory Effect of Damulin B from Gynostemma pentaphyllum on Human Lung Cancer Cells

Authors

  • Shao-Fang Xing*

    1   School of Pharmacy, Minzu University of China, Beijing, China
    2   Key Laboratory of Ethnomedicine (MINZU University of China), Ministry of Education, Beijing, China
  • Lin-Hua Liu*

    3   Department of Biochemistry, Institute of Glycobiology, Dalian Medical University, Liaoning, Dalian, China
  • Ma-Li Zu

    1   School of Pharmacy, Minzu University of China, Beijing, China
    2   Key Laboratory of Ethnomedicine (MINZU University of China), Ministry of Education, Beijing, China
  • Man Lin

    1   School of Pharmacy, Minzu University of China, Beijing, China
    2   Key Laboratory of Ethnomedicine (MINZU University of China), Ministry of Education, Beijing, China
  • Xin-Fang Zhai

    1   School of Pharmacy, Minzu University of China, Beijing, China
    2   Key Laboratory of Ethnomedicine (MINZU University of China), Ministry of Education, Beijing, China
  • Xiang-Lan Piao

    1   School of Pharmacy, Minzu University of China, Beijing, China
    2   Key Laboratory of Ethnomedicine (MINZU University of China), Ministry of Education, Beijing, China
Further Information

Publication History

received 02 June 2018
revised 16 November 2018

accepted 29 November 2018

Publication Date:
18 December 2018 (online)

Preview

Abstract

Damulin B, a dammarane-type saponin from steamed Gynostemma pentaphyllum, exhibits the strongest activity against human lung carcinoma A549 cells among the isolated active saponins. In this study, the structure-activity relationship of a series of saponin compounds was discussed. The inhibitory effect of damulin B on human lung cancer A549 and H1299 cells was investigated from apoptosis, cell cycle, and migration aspects. In vitro, human lung cancer cells were more susceptible to damulin B treatment than human normal fibroblasts. Damulin B exhibited a strong cytotoxic effect, as evidenced by the increase of apoptosis rate, reduction of mitochondrial membrane potential (MMP), generation of reactive oxygen species, and G0/G1 phase arrest. Furthermore, damulin B activated the following: both intrinsic and extrinsic apoptosis pathways along with early G1 phase arrest via the upregulation of the Bax, Bid, tBid, cleaved caspase-8, and p53 expression levels; downregulation of the procaspase-8/-9, CDK4, CDK6, and cyclin D1 expression levels; and more release of cytochrome c in the cytoplasm. In addition, antimigratory activities and suppressive effects on metastasis-related factors, such as MMP-2 and MMP-9, accompanied by the upregulation of IL-24 were revealed. Altogether, the results proved that damulin B could inhibit human lung cancer cells by inducing apoptosis, blocking the cell cycle at early G0/G1 phase and suppressing the migration. Hence, damulin B has potential therapeutic efficacy against lung cancer.

* Authorship note: Shao-Fang Xing and Lin-Hua Liu contributed equally to this work.